PubMed COVID-19 Clinical Care
6461 - 6470 of 7414 results found
Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection
Description
COVID-19 infection has been found to precipitate hypercoagulability and transiently increase antiphospholipid antibodies. However, it is yet to be determined how likely these transient changes contribute to thrombotic events and antiphospholipid
Clinical implications of gut microbiota and cytokine responses in coronavirus disease prognosis
Description
CONCLUSION: Gut microbiota may mediate the prognosis of COVID-19 by regulating cytokine responses and controlling glucose metabolism, which is implicated in the host immune response to SARS-CoV-2.
Community Women's Lifestyle and Eating Disorders in the Era of COVID-19 Pandemic: A 15-Year Follow-Up Study
Description
Most studies suggest that COVID-19 has adversely affected the quality of life and mental health, including eating disorders. However, studies have yet to examine longitudinally the impact of COVID-19 on eating disorder symptomatic individuals. This
Concordance of Central Laboratory HbA1c Measurements from Capillary Kits Compared to Venous Draws in the Insulin-Only Bionic Pancreas Pivotal Trial
Description
Capillary HbA1c collection has grown in importance due to its convenience during situations like the COVID-19 pandemic and virtual visits. The viability of capillary blood samples as an accurate alternative to venous samples has previously only been
Changes in the Hospital Standardized Mortality Ratio Before and During the COVID-19 Pandemic: A Disaggregated Analysis by Region and Hospital Type in Korea
Description
CONCLUSIONS: This study suggests that the COVID-19 pandemic may have negatively impacted the quality of care in hospitals, especially general hospitals with relatively few beds. In light of the COVID-19 pandemic, it is necessary to prevent excessive
COVID-19 Induced Liver Injury from a New Perspective: Mitochondria
Description
Liver damage is a common sequela of COVID-19 (coronavirus disease 2019), worsening the clinical outcomes. However, the underlying mechanism of COVID-induced liver injury (CiLI) is still not determined. Given the crucial role of mitochondria in
Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals
Description
CONCLUSIONS: Current outcomes of high-risk patients with haematological malignancies hospitalized with COVID-19 during Omicron variant predminance are good with the use of early antiviral strategies. Persistent viral shedding is uncommon.
